Amivantamab
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-P9977-1MG | 1 mg | 502,00 | Add | |
| HY-P9977-5MG | 5 mg | 1'239,00 | Add | |
| HY-P9977-10MG | 10 mg | 1'974,00 | Add |
* CHF, excl. 7.7% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
JNJ-61186372
Amivantamab (JNJ-61186372) is a human EGFR-MET bispecific antibody with immune anticancer activity. Amivantamab inhibits ligand binding, promotes endocytosis and degradation of receptor-antibody complexes, and induces Fc-dependent cytokinesis in macrophages and antibody-dependent cytotoxicity in natural killer cells.
| Category | Antibody |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, JAK/STAT Signaling, Protein Tyrosine Kinase/RTK |
| Grade | Clinical information: Launched |
| Purity | 99.59% |
| CAS-Number | 2171511-58-1 |
| Storage Conditions | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Disclaimer | Shipped on dry ice - extra freight charge will occur |
| Product Line | Biosimilar |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Shipping with dry ice |
| Material Safety Data Sheet | Download PDF |
